CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.990
-0.410 (-9.32%)
At close: Feb 27, 2026, 4:00 PM EST
4.023
+0.033 (0.83%)
After-hours: Feb 27, 2026, 5:30 PM EST
CervoMed Market Cap
CervoMed has a market cap or net worth of $36.92 million as of February 27, 2026. Its market cap has increased by 105.18% in one year.
Market Cap
36.92M
Enterprise Value
9.62M
1-Year Change
105.18%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $36.92M, a decrease of -14.67%. That is a compound annual growth rate of -6.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 36.92M | -49.49% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 38.99M |
| PDS Biotechnology | 38.61M |
| Jasper Therapeutics | 38.34M |
| Atossa Therapeutics | 38.23M |
| OnKure Therapeutics | 37.12M |
| NovaBay Pharmaceuticals | 37.10M |
| Tvardi Therapeutics | 37.06M |
| CEL-SCI | 36.98M |